Vivimed Labs receives EIR from USFDA for Mexico facility
New Delhi: Drug firm Vivimed Labs has recently received an establishment inspection report (EIR) from the US health regulator for its Mexico manufacturing facility after an inspection.
"The company's API manufacturing facility located in CUERNAVACA, Mexico was recently inspected by the United States Food and Drug Administration (USFDA) in compliance with their requirements," Vivimed Labs said in a BSE filing.
"The inspection was successful and company obtained EIR. This was a routine inspection by the USFDA," it added.
Vivimed Labs Limited is an India-based global supplier of speciality chemicals and pharmaceuticals. Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics.
Read Also: Vivimed Labs to acquire Hungary-based Soneas
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd